Riskpilot← Back to searchSign inGet full accessAuxMedico Oy
OYDissolvedY-tunnus 2619185-3Lapiosaarenkatu 1-FMedical specialists activities · NACE 8622Est. 2014— employees
Revenue 2025
EUR 64K
-11% vs 2024
EBITDA margin
20.9%
+101% vs 2024
Equity ratio
92.2%
Financial strength
Net profit 2025
EUR 9K
+123% vs 2024
| Revenue | EUR 64K | -11% |
| EBITDA | EUR 13K | +101% |
| Net profit | EUR 9K | +123% |
| Total assets | EUR 37K | -8% |
| Equity | EUR 34K | +0% |
| Employees | — | — |
Legal name
AuxMedico Oy
Y-tunnus number
2619185-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
29. huhtikuuta 2014
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Lääketieteen ja terveydenhuoltoalan tutkimus-, kustannus-, konsultointi-, koulutus-, julkaisu- ja kehitystoiminta. Lisäksi yhtiö tuottaa ja tarjoaa terveys-, terapia- ja lääkäripalveluita ja harjoittaa kaikkea terveydenhuoltoon liittyvää toimintaa. Yhtiö tuottaa myös ICT-palveluja. Yhtiö voi omistaa ja hallita kiinteistöjä, osakkeita ja osuuksia ja muita arvopapereita Suomessa ja ulkomailla, käydä niillä kauppaa, harjoittaa omistamissaan kiinteistöissä ja huoneistoissa vuokraustoimintaa sekä harjoittaa muuta toimialan mukaista rahoitus- ja sijoitustoimintaa.
Address
Lapiosaarenkatu 1-F
Phone
+358505611671
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 74 | 52 | 52 | 71 | 64 |
| Staff expenses | −12 | −12 | −12 | −24 | −13 |
| EBITDA | 24 | 7 | 0 | 7 | 13 |
| Depreciation & amort. | −5 | −4 | −3 | −2 | −2 |
| EBIT | 19 | 4 | −3 | 5 | 12 |
| Net financials | −0 | −0 | 0 | 0 | −0 |
| Profit before tax | 19 | 4 | −3 | 5 | 12 |
| Tax | 4 | 1 | −0 | 0 | 2 |
| Net profit | 15 | 3 | −3 | 4 | 9 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 51 | 43 | 37 | 41 | 37 |
| Equity | 39 | 39 | 33 | 34 | 34 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 12 | 4 | 4 | 6 | 3 |
| Total debt | 12 | 4 | 4 | 6 | 3 |
EBITDA margin
20.9%
This company
15.8%
Market median
+32% vs market
20212025
Equity ratio
92.2%
This company
38.2%
Market median
+141% vs market
20212025
Return on equity
27.2%
This company
18.4%
Market median
+48% vs market
20212025
Net profit margin
14.7%
This company
8.1%
Market median
+81% vs market
20212025
Asset turnover
1.70×
This company
1.12×
Market median
+52% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KO Deputy Member | Deputy Member | 2014 |
| Former (1) | ||
JA | Audit | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2014 | |
| Chairperson | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AuxMedico Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kari Olavi Järventausta | Deputy Member | 0 companies |
| Joonas Aleksi Pekkinen | Audit | 0 companies |
| Kaija Maarit Järventausta | Board of Directors | 0 companies |
| Pirkko Marjatta Järventausta | Chairperson | 0 companies |